Appearance of annular ring-like intermediates during amyloid fibril formation from human serum albumin.
Shruti Arya, Arpana Kumari, Vijit Dalal, Mily Bhattacharya, Samrat Mukhopadhyay
文献索引:Phys. Chem. Chem. Phys. 17 , 22862-71, (2015)
全文:HTML全文
摘要
The self-assembly of proteins triggered by a conformational switch into highly ordered β-sheet rich amyloid fibrils has captivated burgeoning interest in recent years due to the involvement of amyloids in a variety of human diseases and a diverse range of biological functions. Here, we have investigated the mechanism of fibrillogenesis of human serum albumin (HSA), an all-α-helical protein, using an array of biophysical tools that include steady-state as well as time-resolved fluorescence, circular dichroism and Raman spectroscopy in conjunction with atomic force microscopy (AFM). Investigations into the temporal evolution of nanoscale morphology using AFM revealed the presence of ring-like intermediates that subsequently transformed into worm-like fibrils presumably by a ring-opening mechanism. Additionally, a multitude of morphologically-diverse oligomers were observed on the pathway to amyloid formation. Kinetic analysis using multiple structural probes in-tandem indicated that HSA amyloid assembly is a concerted process encompassing a major structural change that is primarily mediated by hydrophobic interactions between thermally-induced disordered segments originating in various domains. A slower growth kinetics of aggregates suggested that the protein structural reorganization is a prerequisite for fibril formation. Moreover, time-dependent Raman spectroscopic studies of HSA aggregation provided key molecular insights into the conformational transitions occurring within the protein amide backbone and at the residue-specific level. Our data revealed the emergence of conformationally-diverse disulfides as a consequence of structural reorganization and sequestration of tyrosines into the hydrophobic amyloid core comprising antiparallel cross β-sheets.
相关化合物
相关文献:
2015-03-01
[Pharm. Dev. Technol. 20(2) , 169-75, (2015)]
2014-07-18
[ACS Chem. Biol. 9(7) , 1595-602, (2014)]
2014-08-01
[J. Pharm. Biomed. Anal. 97 , 141-50, (2014)]
2015-02-01
[Drug Test. Anal. 7(2) , 131-42, (2015)]
2015-01-01
[MAbs 7(2) , 403-12, (2015)]